Response to Letter  by Shalhoub, J. et al.
Eur J Vasc Endovasc Surg (2009) 38, 137e138CORRESPONDENCEDon’t Overlook Minimally Invasive Colorectal Cancer
Surgery
Dear Editor,
We were interested to read the paper by Shalhoub et al. on
the topic of concurrent aortic aneurysmal disease and
colorectal cancer.
Their series reported a median stay of 13 days following
colorectal surgery and demonstrated the advantages of
a minimally invasive approach to aortic surgery. They fail
to mention, however the benefits of laparoscopic colo
rectal surgery (LCS) which, combined with EVAR, may
have considerable advantages. The authors mention the
commonly cited reasons for the concern over interval aneu-
rysm rupture following colorectal resection including cyto-
kine release, impaired nutrition and the trauma of surgical
dissection. LCS would diminish these risks.
LCS provides a faster recovery of immunological
homeostasis and lower peak levels of IL-6 and other
cytokines1 when compared with open surgery. The increase
in matrix metalloproteinase-9 associated with aneurysm
rupture and seen following open colorectal resection is
absent following LCS.2
The impaired nutrition formerly associated with open
surgery has largely been superseded by LCS within
enhanced recovery programmes3 such that a median stay of
3 days is possible and has been achieved at our institution
for all laparoscopic colonic resections over the past year.
Tissue trauma and adhesion formation from surgical
dissection are also reduced in LCS.1
We suggest that a combination of EVAR and LCS may be
the optimum treatment combination for some of these
patients and should be included in the paradigm.
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Response to Letter
Dear Editor,
We would like to thank Drs Conaghan and Acheson for their
interest in our article and for their comments. We
congratulate them on the length of stay for their cohort of
laparoscopic colonic cases, which is not dissimilar to those
from our colorectal unit. The median length of stay in our
series is following open surgery and undoubtedly reflects
the comorbidities of these groups of patients.
Laparoscopic resection is increasingly being used for
colorectal cancer (CRC)1 and has indeed been associated
with a reduced inflammatory response compared with open
surgery.2 Although this may theoretically reduce the risk of
interval abdominal aortic aneurysm (AAA) rupture, there
are no reliable data available regarding the risk of AAA
rupture after laparoscopic CRC treatment. We have shown
that this interval rupture risk is low for AAAs of 6 cm or
smaller with open CRC surgery.
Also, we agree the use of an enhanced recovery proto-
cols following laparoscopic colorectal surgery is appealing
in that it may further benefit this group of patients,
however when a multimodal rehabilitation programme is
used in open surgery as well, the benefits of laparoscopicDOI of original article: 10.1016/j.ejvs.2009.01.004.
138 Correspondencesurgery may not be quite so clear cut.3 The EnROL study
that has just started recruiting in the UK will help clarify
this issue.4
References
1 Tong DKH, Fan JKM, Law WL. Outcome of laparoscopic colorectal
resection. Surgeon 2008 Dec;6(6):357e60.
2 Hartley JE, Mehigan BJ, Monson JR. Alterations in the immune
system and tumor growth in laparoscopy. Surg Endosc 2001 Mar;
15(3):305e13.
3 Basse L, Jakobsen DH, Bardram L, Billesbølle P, Lund C,
Mogensen T, et al. Functional recovery after open versus lapa-
roscopic colonic resection: a randomized, blinded study. Ann
Surg 2005 Mar;241(3):416e23.
4 www.octo-oxford.org.uk/alltrials/trials/EnROL.html.J. Shalhoub*
P. Naughton
P. Ziprin
Department of Bio Surgery & Surgical Technology,
Faculty of Medicine, Imperial College London,
St Mary’s Hospital, Praed Street,
London W2 1NY, UK
*Corresponding author.
E-mail address: j.shalhoub@imperial.ac.uk (J. Shalhoub)
Available online 6 May 2009
ª 2009 European Society for Vascular Surgery. Published by Elsevier
Ltd. All rights reserved.
doi:10.1016/j.ejvs.2009.03.022
